Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Argonaut Technologies (NasdaqNM:AGNT)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Location
887 Industrial Road, Suite G
San Carlos, CA 94070
Phone: (650) 598-1350
Fax: (650) 598-1359
Email: info@argotech.com
Employees (last reported count): 110
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 53%
·Institutional: 37% (79% of float)
(38 institutions)
·Net Inst. Buying: 1.69M shares (+19.22%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Argonaut Technologies, Inc. develops products that help chemists engaged in the discovery and development of new molecules increase their productivity and reduce their operating costs without compromising the scientific integrity of their research. The Company's products include instruments and instrument related consumables, and reagents. Argonaut has designed each of its instrument products for a specific stage of development, although chemists often purchase the Company's instruments to perform chemistry activities in stages other than those for which they were initially designed. The Company's reagents are used by chemists to perform a broad range of chemistries in lead optimization and pre-clinical development and can be used in conjunction with its instruments or independently.
More from Market Guide: Expanded Business Description

Financial Summary
Argonaut Technologies develops, manufactures, and markets products that enable chemists to use high speed parallel synthesis for the development of new drugs. The Company's products include parallel chemical synthesizers and reagents. For the six months ended 6/30/01, net sales rose 3% to $7.9 million. Net loss rose 52% to $7.2 million. Results reflect improvements in consumable products and services, offset by increased stock compensation and R&D expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

David Binkley, Ph.D., 47
Chairman, CEO
$324K$817K
Lissa Goldenstein, 45
Pres, COO
263K269K
Jan Hughes, 40
Sr. VP, CTO
189K203K
John Supan, 50
VP-Fin., CFO
--  --  
Doug Heigel, 40
VP, Manufacturing
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:AGNTAs of 31-Aug-2001
Price and Volume
52-Week Low
on 19-July-2001
$4.05 
Recent Price$4.25 
52-Week High
on 19-Sep-2000
$22.50 
Daily Volume (3-month avg)32.5K
Daily Volume (10-day avg)5,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-75.3%
52-Week Change
relative to S&P500
-66.8%
Share-Related Items
Market Capitalization$81.5M
Shares Outstanding19.2M
Float9.00M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$4.00 
Earnings (ttm)-$0.55 
Earnings (mrq)-$0.24 
Sales (ttm)$1.00 
Cash (mrq)$3.30 
Valuation Ratios
Price/Book (mrq)1.06 
Price/EarningsN/A 
Price/Sales (ttm)4.26 
Income Statements
Sales (ttm)$17.7M
EBITDA (ttm)-$13.2M
Income available to common (ttm)-$9.97M
Profitability
Profit Margin (ttm)-56.4%
Operating Margin (ttm)-76.1%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-14.36%
Return on Equity (ttm)-15.62%
Financial Strength
Current Ratio (mrq)15.64 
Debt/Equity (mrq)0.01 
Total Cash (mrq)$63.3M
Short Interest
As of 8-Aug-2001
Shares Short11.0K
Percent of Float0.1%
Shares Short
(Prior Month)
12.0K
Short Ratio0.85 
Daily Volume13.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.